When was Nami Pharma founded?

Nami Pharma was founded in 2009.

Where is Nami Pharma located?

Nami Pharma is headquartered in Hyderabad, India. It is registered at Plot no -47/B Biotech Park, PH -III, Karkapatla, Markook, Siddipet, Siddipet, Siddipet, Telangana, India, 502279.

Is Nami Pharma a funded company?

Nami Pharma is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Nami Pharma?

Annual revenue of Nami Pharma is ₹14.3Cr as on Mar 31, 2025.

Where does Nami Pharma rank among its competitors?

Nami Pharma ranks 510th amongst 1104 active competitors, of which 36 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Nivagen Pharmaceuticals, which secured $5M in Aug, 2023.

Who are the top competitors of Nami Pharma?

Nami Pharma's top competitors include Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals. Among them, Nivagen Pharmaceuticals secured the most recent funding round in August, 2023.

Nami Pharma - 2026 Company Profile, Competitors & Financials

Nami Pharma is an unfunded company based in Hyderabad (India), founded in 2009. It operates as a Manufacturer of tablets, granules, pellets, and capsules. Nami Pharma has not raised any funding yet. The company has 1104 active competitors, including 36 funded and 159 that have exited. Its top competitors include companies like Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals.

Company Details

Nami Pharma manufactures tablets, granules, pellets, and capsules. The products are of various therapeutic categories including gastrointestinal, analgesics, anticancer, antidiabetic, cardiovascular, and others.

Website: namipharma.com
Email ID: *****@namipharma.com, *****@namipharma.com
Phone Number: +91 **********, +91 **********
Registered Address: Plot no -47/B Biotech Park, PH -III, Karkapatla, Markook, Siddipet, Siddipet, Siddipet, Telangana, India, 502279

Key Metrics

Founded Year

2009

Location

Hyderabad, India

Stage

Unfunded

Ranked

510^th among 1104 active competitors

Annual Revenue

₹14.3Cr as on Mar 31, 2025

Similar Companies

Suzhou Ze Jing Biological Pharmaceutical & 267 more

View Nami Pharma's full profile

Nami Pharma is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NAMI LIFESCIENCES PRIVATE LIMITED CIN: U24304TG2016PTC111480 , India, Active	Aug 16, 2016	$1.69M (As on Mar 31, 2025)	-

Nami Pharma has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nami Pharma include Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals. Here is the list of Top 10 competitors of Nami Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jubilant Life Sciences 1978, Noida (India), Public	Company offering a suite of R&D and manufacturing services for small molecules and generics	-	Samena Capital, General Atlantic & 1 others	59/100
2nd	Akums 2004, Delhi (India), Public	CDMO focusing on spectrum of dosage forms and therapeutic segments	$70M	Quadria Capital & 5 others	58/100
3rd	Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired	Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution	$31M	Telegraph Hill Partners, BizCap & 1 others	57/100
4th	SAVA group 2003, Pune (India), Unfunded	Pharma company with a portfolio of domestic and export products, also offering CRAMS services	-	-	56/100
5th	Nectar Lifesciences 1995, Chandigarh (India), Public	Manufacturer of cephalosporin APIs and generic formulations	$46.9M	Vedanta Capital, NSR Partners & 1 others	55/100
6th	Recipharm 1995, Jordbro (Sweden), Acquired	Contract services for pharmaceutical development and manufacturing	-	Ampersand Capital, CPP Investments	55/100
7th	Supriya Lifescience 2008, Mumbai (India), Public	Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare	-	-	54/100
8th	Suzhou Ze Jing Biological Pharmaceutical 2009, Suzhou (China), Series B	Company developing small molecules & eukaryotic cell based recombinant protein drugs	$61.9M	Share Capital, Shenzhen Capital Group & 8 others	54/100
9th	Chugai Pharmaceutical 1925, Tokyo (Japan), Acquired	Developer of innovative pharmaceutical products and services	-	Digital Pharma Lab	54/100
10th	Asahi Kasei 1931, Chiyoda-ku (Japan), Public	CDMO focused on manufacturing of liquid, solid & injectable drug formulations	-	Europa	53/100
510th	Nami Pharma 2009, Hyderabad (India), Unfunded	Manufacturer of tablets, granules, pellets, and capsules	-	-	25/100